The PNH and aHUS Market was anticipated to grow from US$ 4855 million in 2020 to US$ 7023 million by 2028; it is expected to grow at a CAGR of 5% during the forecast period 2022–2028. Paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) are both sporadic and hereditary disorders. In PNH, the […]
